FDA Orange Book · active-ingredient family
Isoniazid
Isoniazid is approved as 6 brand and 38 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ISONIAZID · NDA 008678
6
Brand (NDA)
38
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, syrup, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ISONIAZIDRLD×2 | EPIC PHARMA LLC | NDA 008678 | — | Approved Prior to Jan 1, 1982 | |
| NYDRAZID | SANDOZ | NDA 008662 | — | Approved Prior to Jan 1, 1982 | |
| RIMIFON×3 | ROCHE | NDA 008420 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID×2 | LILLY | NDA 008499 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID×3 | PANRAY | NDA 008428 | — | Approved Prior to Jan 1, 1982 | |
| NYDRAZID | BRISTOL MYERS SQUIBB | NDA 008392 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (38)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ISONIAZID×2 | THEPHARMANETWORK LLC | ANDA 202610 | AA | Oct 29, 2014 | |
| ISONIAZID | SANDOZ | ANDA 040648 | — | Jul 05, 2005 | |
| ISONIAZID | CHARTWELL RX | ANDA 081118 | AA | Jul 21, 1997 | |
| ISONIAZID×2 | OMNIVIUM PHARMS | ANDA 040090 | AA | Jun 26, 1997 | |
| LANIAZID | CHARTWELL MOLECULAR | ANDA 089776 | — | Jun 13, 1988 | |
| LANIAZID | LANNETT | ANDA 089243 | — | Feb 03, 1986 | |
| ISONIAZIDRLD | CMP PHARMA INC | ANDA 088235 | AA | Nov 10, 1983 | |
| ISONIAZID | DURAMED PHARMS BARR | ANDA 088231 | — | Mar 17, 1983 | |
| ISONIAZID | DURAMED PHARMS BARR | ANDA 088119 | — | Mar 17, 1983 | |
| ISONIAZID×2 | PUREPAC PHARM | ANDA 080132 | — | Jul 14, 1982 | |
| DOW-ISONIAZID | DOW PHARM | ANDA 080330 | — | Approved Prior to Jan 1, 1982 | |
| HYZYD×2 | MEDPOINTE PHARM HLC | ANDA 080134 | — | Approved Prior to Jan 1, 1982 | |
| INH | NOVARTIS | ANDA 080935 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | GENUS | ANDA 080936 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | GENUS | ANDA 080937 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | HALSEY | ANDA 083632 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | HIKMA INTL PHARMS | ANDA 080212 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | HIKMA INTL PHARMS | ANDA 087425 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | IMPAX LABS | ANDA 080153 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | IVAX SUB TEVA PHARMS | ANDA 080270 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | IVAX SUB TEVA PHARMS | ANDA 083610 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | MK LABS | ANDA 080941 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | NEXGEN PHARMA INC | ANDA 084050 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | PERRIGO | ANDA 083060 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | PHARMAVITE | ANDA 085091 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID×2 | PHOENIX LABS NY | ANDA 080368 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | SUN PHARM INDUSTRIES | ANDA 080136 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | SUN PHARM INDUSTRIES | ANDA 083633 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 080522 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 080401 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 080523 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 085790 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 080521 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 083178 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WATSON LABS | ANDA 085784 | — | Approved Prior to Jan 1, 1982 | |
| ISONIAZID | WHITEWORTH TOWN PLSN | ANDA 080120 | — | Approved Prior to Jan 1, 1982 | |
| LANIAZID×2 | CHARTWELL MOLECULAR | ANDA 080140 | — | Approved Prior to Jan 1, 1982 | |
| STANOZIDE×2 | EVERYLIFE | ANDA 080126 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Isoniazid — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

